1316eTiP A phase Ib trial of CS5001 (ROR1-ADC) as a single agent and in combination with systemic therapies in patients with advanced solid tumours and lymphomas.
Saved in:
| Title: | 1316eTiP A phase Ib trial of CS5001 (ROR1-ADC) as a single agent and in combination with systemic therapies in patients with advanced solid tumours and lymphomas. |
|---|---|
| Authors: | Song, Y.1 (AUTHOR), Xie, L.2 (AUTHOR), Zhang, Y.2 (AUTHOR), Wu, H.3 (AUTHOR), Pratyush, G.4 (AUTHOR), Huang, H.5 (AUTHOR), Cen, H.6 (AUTHOR), Guo, Y.7 (AUTHOR), Fan, L.8 (AUTHOR), Li, Y.9 (AUTHOR), Li, M.10 (AUTHOR), Sun, X.11 (AUTHOR), Liang, X.3 (AUTHOR), Lemech, C.12 (AUTHOR), Wang, J.13 (AUTHOR), Zhu, X.13 (AUTHOR), Li, F.13 (AUTHOR), Dai, H.13 (AUTHOR), Shi, Q.13 (AUTHOR), Yang, J.J.13 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS822-S823. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1947 |
